Coastal Bend Blood Center FDA Inspection Record
Coastal Bend Blood Center is an FDA-inspected facility (FEI 1671283) located in Corpus Christi, TX, US. RegDataLab tracks 7 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Mar 28, 2025: No Action Indicated (NAI)
- Inspections on record
- 7 (2 VAI, 5 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 29, latest Mar 5, 2025
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Mar 28, 2025 | No Action Indicated (NAI) | No citations listed |
| Jun 13, 2019 | No Action Indicated (NAI) | No citations listed |
| Jul 14, 2017 | Voluntary Action Indicated (VAI) | Equipment calibration frequency (21 CFR 606.60(b)) |
| Jun 17, 2015 | No Action Indicated (NAI) | No citations listed |
| Apr 12, 2013 | No Action Indicated (NAI) | No citations listed |
| Jun 15, 2011 | No Action Indicated (NAI) | No citations listed |
| Jun 8, 2009 | Voluntary Action Indicated (VAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Mar 5, 2025 | Class II | B-0058-2026 | Red Blood Cells, Leukocytes Reduced Red Blood Cells, Leukocytes Reduced, collected from a donor who had traveled to an area designated as endemic for malaria, were distributed. |
| Feb 21, 2024 | Class II | B-0259-2024 | Red Blood Cells, Leukocytes Reduced, Irradiated Red Blood Cell products, for which donor eligibility was incomplete, were distributed. |
| Jan 15, 2024 | Class II | B-0194-2024 | Apheresis Platelets, Leukocytes Reduced Apheresis Platelet products, collected from a donor whose suitability to donate was not adequately determined, were distributed. |
| Mar 24, 2023 | Class II | B-0590-2023 | Red Blood Cells, Leukocytes Reduced Leukoreduced Red Blood Cells, collected from a donor who had recently traveled to a malarial endemic area, were distributed. |
| Sep 9, 2022 | Class II | B-0288-2023 | Red Blood Cells, Leukocytes Reduced, Irradiated Leukoreduced Red Blood Cell products, which were inadequately irradiated due to lack of calibration of the irradiation device, were… |
| Jun 1, 2022 | Class III | B-0007-2023 | Apheresis Red Blood Cells, Leukocytes Reduced Red Blood Cell product, which were processed with expired reagents, was distributed. |
| Aug 9, 2021 | Class III | B-0614-2021 | Pooled Cryoprecipitated AHF Pooled Cryoprecipitated AHF, which did not have cryo QC performed, was distributed. |
| Jul 17, 2021 | Class II | B-0548-2021 | Platelets and 1 more product Blood products, collected from a donor who lived in a malarial endemic area, were distributed. |
| Nov 16, 2020 | Class II | B-0184-2021 | Platelets Platelet product, collected from a donor previously deferred for testing reactive for syphilis and was not properly tested for re-entry, was… |
| Nov 13, 2020 | Class III | B-0233-2021 | Red Blood Cells, Leukocytes Reduced Misbranded Blood Products were distributed. |
FDA record score
21 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
26 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall B-0058-2026, this FEI as the recalling firm | Mar 5, 2025 | 4 x 1 | 4 |
| Class II recall B-0259-2024, this FEI as the recalling firm | Feb 21, 2024 | 4 x 0.6 | 2.4 |
| Class II recall B-0194-2024, this FEI as the recalling firm | Jan 15, 2024 | 4 x 0.6 | 2.4 |
| Class II recall B-0590-2023, this FEI as the recalling firm | Mar 24, 2023 | 4 x 0.6 | 2.4 |
| Class II recall B-0288-2023, this FEI as the recalling firm | Sep 9, 2022 | 4 x 0.6 | 2.4 |
| Inspection classified VAI | Jul 14, 2017 | 6 x 0.25 | 1.5 |
| Class II recall B-0548-2021, this FEI as the recalling firm | Jul 17, 2021 | 4 x 0.25 | 1 |
| Class II recall B-0184-2021, this FEI as the recalling firm | Nov 16, 2020 | 4 x 0.25 | 1 |
| Class II recall B-0138-2021, this FEI as the recalling firm | Oct 30, 2020 | 4 x 0.25 | 1 |
| Class II recall B-0534-2020, this FEI as the recalling firm | Mar 18, 2020 | 4 x 0.25 | 1 |
| Class II recall B-0728-2017, this FEI as the recalling firm | May 24, 2017 | 4 x 0.25 | 1 |
| Class II recall B-0339-2017, this FEI as the recalling firm | Dec 19, 2016 | 4 x 0.25 | 1 |
| Class II recall B-0293-2017, this FEI as the recalling firm | Nov 7, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0294-16, this FEI as the recalling firm | Jan 27, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0796-14, this FEI as the recalling firm | May 9, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1613-13, this FEI as the recalling firm | Feb 20, 2013 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1194-13, this FEI as the recalling firm | Feb 4, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jun 8, 2009 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0480-08, this FEI as the recalling firm | Feb 13, 2007 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0621-08, this FEI as the recalling firm | Apr 28, 2006 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0295-7, this FEI as the recalling firm | Sep 12, 2005 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0292-7, this FEI as the recalling firm | May 2, 2005 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1582-5, this FEI as the recalling firm | Dec 3, 2004 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1393-5, this FEI as the recalling firm | Apr 1, 2003 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1060-5, this FEI as the recalling firm | Sep 19, 2002 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1360-5, this FEI as the recalling firm | Sep 8, 2002 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 14, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 14, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 2, 2026 | Newest record Oct 22, 2026 | Current |
Reviewing Coastal Bend Blood Center as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Coastal Bend Blood Center yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Coastal Bend Blood Center
- Location
- Corpus Christi, TX (US)
- Source
- inspections